SELB - Selecta Biosciences GAAP EPS of -$0.07 beats by $0.01 revenue of $5.2M misses by $5.89M
2023-08-17 07:58:15 ET
More on Selecta Biosciences
- Selecta surges ~20% as gout drug SEL-212 meets main goal in 2 phase 3 trials
- Selecta Biosciences stock rises 10% on license deal with Astellas for Xork
For further details see:
Selecta Biosciences GAAP EPS of -$0.07 beats by $0.01, revenue of $5.2M misses by $5.89M